State Street’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

State Street’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,490	Closed	-$20K	–	4968
2022 Q2	$20K	Buy	3,490 +2,138	+158%	+$19.4K	﹤0.01%	4874
2022 Q1	$16K	Hold	1,352	–	–	﹤0.01%	4897
2021 Q4	$14K	Hold	1,352	–	–	﹤0.01%	4785
2021 Q3	$44K	Hold	1,352	–	–	﹤0.01%	4649
2021 Q2	$58K	Buy	+1,352	New	+$55.6K	﹤0.01%	4419
2016 Q2	–	Sell	-12	Closed	-$14K	–	3777
2016 Q1	$14K	Hold	12	–	–	﹤0.01%	3684
2015 Q4	$15K	Hold	12	–	–	﹤0.01%	3671
2015 Q3	$17K	Hold	12	–	–	﹤0.01%	3672
2015 Q2	$27K	Sell	12 -2	-14%	-$6.27K	﹤0.01%	3654
2015 Q1	$42K	Hold	14	–	–	﹤0.01%	3592
2014 Q4	$46K	Sell	14 -1	-7%	-$3.54K	﹤0.01%	3596
2014 Q3	$54K	Hold	15	–	–	﹤0.01%	3564
2014 Q2	$59K	Sell	15 -354	-96%	-$1.33M	﹤0.01%	3525
2014 Q1	$1.5M	Buy	369 +1	+0.3%	+$4.46K	﹤0.01%	3162
2013 Q4	$1.36M	Sell	368 -31	-8%	-$117K	﹤0.01%	3195
2013 Q3	$1.57M	Sell	399 -1	-0.3%	-$7.5K	﹤0.01%	3132
2013 Q2	$3.94M	Buy	+400	New	+$4.43M	﹤0.01%	2599

Other funds holding FRTX

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street's FRTX Position: Q3 2022 in Review

State Street sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q3 2022, closing a stake of 3,490 shares — an estimated $20K sold.

State Street first reported a position in FRTX in Q2 2013 and held it in 17 quarters. The position peaked at $3.94M in Q2 2013. 17 funds tracked by Wall St. Rank hold FRTX as of Q3 2022.

State Street reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
State Street sold 3,490 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $20K.
State Street first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 17 quarters.
State Street's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $3.94M in Q2 2013.
17 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q3 2022.

Based on State Street's 13F filing for Q3 2022, filed 15 Nov 2022.